Skip to main content

Sea Pharmaceuticals

Cambridge, United States

Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.

$417K raised
Feb 2025
Undisclosed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sea Pharmaceuticals

How much funding has Sea Pharmaceuticals raised?
Sea Pharmaceuticals has raised $417K in total funding. The most recent round was Undisclosed. The last funding was announced in February 2025.
Where is Sea Pharmaceuticals headquartered?
Sea Pharmaceuticals is headquartered in Cambridge, United States.
What does Sea Pharmaceuticals do?
Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.
What stage is Sea Pharmaceuticals at?
Sea Pharmaceuticals is at the Undisclosed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sea Pharmaceuticals — Funding & Investors." VCBacked, February 10, 2025, https://www.vcbacked.co/company/sea-pharmaceuticals. Accessed July 3, 2026.
APA
VCBacked. (2025). Sea Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/sea-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Sea Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/sea-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .